FDA Inspection 1215398 — Emergent Biodefense Operations Lansing LLC

Emergent Biodefense Operations Lansing LLC — FEI 3004051669

The FDA completed an inspection of Emergent Biodefense Operations Lansing LLC on August 16, 2023 in Canton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 16, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Canton, MA (United States)